Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

E-VarEndo

Financiado

Metastable Epiallele: Role of Epigenetic Variability for the Development of Meta...

Metastable Epiallele: Role of Epigenetic Variability for the Development of Metabolic and Endocrine Diseases The development of obesity in industrial and low-and middle-income countries is leading to a severe burden for patients and health care systems based on associated comorbidities as cardiovascular diseases and type 2 diabetes melli... ver más

31/01/2028

CHARITE UNIVERSIT...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-10-25

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2021-COG: ERC CONSOLIDATOR GRANTS

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

CHARITE UNIVERSITAETSMEDIZI...

2.00M€ | Lider

Proyectos interesantes

SAF2011-23649 ESTUDIO DE LOS CAMBIOS EN LA REMODELACION DE CROMATINA POR L... 48K€ Cerrado

SAF2017-84542-R HERENCIA NO-GENOMICA DE LA OBESIDAD MEDIANTE ARNS NO CODIFIC... 145K€ Cerrado

BFU2011-29739 LA NUTRICION PERINATAL EN MACHOS PROGRAMA LA EXPRESION DE GE... 127K€ Cerrado

PID2021-126441NB-I00 CRONOBIOLOGIA DURANTE EL DESARROLLO NEONATAL: IMPLICACIONES... Cerrado

SAF2011-27086 REGULACION EPIGENETICA DE LAS CELULAS BETA Y DIABETES 436K€ Cerrado

IJC2019-040796-I Mecanismos epigenéticos y genéticos en enfermedades metabóli... 93K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 63 meses Fecha Inicio: 2022-10-25
Fecha Fin: 2028-01-31

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto The development of obesity in industrial and low-and middle-income countries is leading to a severe burden for patients and health care systems based on associated comorbidities as cardiovascular diseases and type 2 diabetes mellitus. Apart from the genetic background, epigenetic modifications like DNA methylation are supposed to play an important role for body weight regulation. So far, epigenome-wide association studies were not able to elucidate this relationship, as most methylation differences were related to a genetic variant. Therefore, the identification of the POMC (pro-opiomelanocortin) gene, a key factor for hypothalamic body weight regulation, as a metastable epiallele in humans, was of importance to understand how methylation variability affect the individual phenotype. Metastable epialleles are methylome-regions, which are non-genetically determined, stochastically regulated and set in early embryonic development. Furthermore, they are non-tissue specific, stable over time and modified by Carbon-1 metabolites in-utero. However, their role for human diseases remained unclear. Within this application, I want to elucidate and characterize how epigenetic modifications as metastable epialleles modulate human susceptibility and predisposition to metabolic and endocrine diseases and analyse the impact of environmental factors. To achieve this goal, I propose a unique approach using advanced technologies to analyse human postmortem samples and human embryonic stem cells to identify new metastable epialleles in humans and elucidate new mechanisms and relationships between phenotypic variation and methylation variability. The combination of the algorithm to identify methylation variability and the use of stem cell models to functionally characterize epigenetic variants will be a blueprint for the analysis of the epigenetic contribution for other endocrine, neurological or cardiovascular diseases and will generate a powerful resource for researchers worldwide.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores